Style | Citing Format |
---|---|
MLA | Namazi N, et al.. "Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study." Journal of Diabetes and Metabolic Disorders, vol. 18, no. 2, 2019, pp. 409-417. |
APA | Namazi N, Kelishadi R, Heshmat R, Motlagh ME, Sanaei M, Shafiee G, Ziaodini H, Beshtar S, Taheri M, Aminaee T, Qorbani M, Shahrzad MK (2019). Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study. Journal of Diabetes and Metabolic Disorders, 18(2), 409-417. |
Chicago | Namazi N, Kelishadi R, Heshmat R, Motlagh ME, Sanaei M, Shafiee G, Ziaodini H, et al.. "Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study." Journal of Diabetes and Metabolic Disorders 18, no. 2 (2019): 409-417. |
Harvard | Namazi N et al. (2019) 'Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study', Journal of Diabetes and Metabolic Disorders, 18(2), pp. 409-417. |
Vancouver | Namazi N, Kelishadi R, Heshmat R, Motlagh ME, Sanaei M, Shafiee G, et al.. Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study. Journal of Diabetes and Metabolic Disorders. 2019;18(2):409-417. |
BibTex | @article{ author = {Namazi N and Kelishadi R and Heshmat R and Motlagh ME and Sanaei M and Shafiee G and Ziaodini H and Beshtar S and Taheri M and Aminaee T and Qorbani M and Shahrzad MK}, title = {Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {18}, number = {2}, pages = {409-417}, year = {2019} } |
RIS | TY - JOUR AU - Namazi N AU - Kelishadi R AU - Heshmat R AU - Motlagh ME AU - Sanaei M AU - Shafiee G AU - Ziaodini H AU - Beshtar S AU - Taheri M AU - Aminaee T AU - Qorbani M AU - Shahrzad MK TI - Determinants of Taking Dietary Supplements in Iranian Children and Adolescents: The Caspian-V Study JO - Journal of Diabetes and Metabolic Disorders VL - 18 IS - 2 SP - 409 EP - 417 PY - 2019 ER - |